Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.2936
-0.0134 (-4.36%)
Aug 4, 2025, 2:23 PM - Market open

Verve Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
914534644-
Upgrade
Market Cap Growth
-77.73%-73.92%14.29%4.51%--
Upgrade
Enterprise Value
48463630-
Upgrade
Last Close Price
0.310.813.833.984.32-
Upgrade
PB Ratio
2.9722.3511.306.313.56-
Upgrade
P/TBV Ratio
3.9122.3511.306.313.56-
Upgrade
Debt / Equity Ratio
-----0.03
Upgrade
Quick Ratio
1.861.162.504.4215.366.72
Upgrade
Current Ratio
1.931.192.534.5515.716.82
Upgrade
Return on Equity (ROE)
-285.79%-534.03%-243.33%-122.61%-168.71%-261.26%
Upgrade
Return on Assets (ROA)
-106.67%-152.41%-106.65%-66.79%-97.21%-99.91%
Upgrade
Return on Capital (ROIC)
-178.62%-333.77%-152.08%-76.63%-105.53%-160.26%
Upgrade
Earnings Yield
-131.53%-102.56%-27.64%-26.21%-28.88%-
Upgrade
Buyback Yield / Dilution
-26.96%-27.56%-17.15%-26.72%-37.88%-30.29%
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q